Contineum initiated with an Outperform at William Blair
William Blair initiated coverage of Contineum (CTNM) with an Outperform rating. Contineum is a clinical-stage biotech developing small-molecule therapeutics for indications in the neuroinflammation and immunology space developing PIPE-791, a wholly owned asset for the treatment of idiopathic pulmonary fibrosis, progressive forms of multiple sclerosis and chronic pain indications, notes the analyst, who sees a fair value of $23.26 per share.
Confident Investing Starts Here:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
QXO (QXO) Bullish Rating Propels Stock by 11.66%
We recently published a list of These 10 Stocks Boast Double-Digit Gains Amid Boring Market. QXO Inc. (NYSE:QXO) is one of the best-performing stocks on Thursday. QXO extended its winning streak to a third consecutive day on Wednesday, jumping 11.66 percent to finish at $22.50 apiece as investor sentiment was buoyed by an investment firm's bullish rating for its stock. In its first coverage of QXO Inc. (NYSE:QXO), investment firm William Blair & Company gave an 'outperform' rating on its stock with a target range between $27 and $44. The price target gives QXO Inc.'s (NYSE:QXO) stock as much as 95-percent upside from its latest closing price. According to William Blair, QXO Inc. (NYSE:QXO) has the potential to become a major player in the $800-billion building products distribution industry. The analyst rating followed the company's acquisition of Beacon Building Products for $11 billion, making it the largest publicly traded distributor of roofing, waterproofing, and complementary building products in the United States. dcwcreations/ William Blair expects QXO Inc. (NYSE:QXO) to pursue another large acquisition as part of its 'big game hunting' strategy, and propel its revenues to $50 billion in revenue in the next decade. While we acknowledge the potential of QXO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Business Insider
2 days ago
- Business Insider
Contineum initiated with an Outperform at William Blair
William Blair initiated coverage of Contineum (CTNM) with an Outperform rating. Contineum is a clinical-stage biotech developing small-molecule therapeutics for indications in the neuroinflammation and immunology space developing PIPE-791, a wholly owned asset for the treatment of idiopathic pulmonary fibrosis, progressive forms of multiple sclerosis and chronic pain indications, notes the analyst, who sees a fair value of $23.26 per share. Confident Investing Starts Here:
Yahoo
3 days ago
- Yahoo
Why Remitly Global Stock Finished Up Almost 6% Today
One Wall Street analyst believes the "One Big Beautiful Bill Act" going through the Senate could be a tailwind for Remitly. Because of its focus on remittances, Remitly has exposure to regulatory risk. The company is on track for another year of strong growth. 10 stocks we like better than Remitly Global › Shares of Remitly Global (NASDAQ: RELY) finished higher Tuesday on signs that the "Big, Beautiful Bill" moving through Congress could be less burdensome than initially expected, as one Wall Street analyst pointed out, after Senate revisions to the bill. As a result, shares of Remitly, which facilitates remittance payments, closed on Tuesday up 5.7% even as the broad market was down nearly 1%. According to a note from William Blair, Senate Republicans proposed "less onerous" restrictions in the tax and budget bill than investors had previously feared. William Blair even speculated that the bill, as currently proposed, could be a tailwind for Remitly, leading to increased adoption of digital remittances. Currently, the company competes with Western Union and Moneygram, as well as more traditional methods of remittances. The bill in the House had proposed a 3.5% excise tax on remittances, which would have imposed an additional burden on immigrants sending money home and could have led them to use methods like money orders that could more easily avoid the tax. Remitly investors should keep an eye on the bill, as any change in policy around remittances is likely to affect the company. Thus far, the Trump administration's crackdown on immigration doesn't seem to have had an effect on the company's business. First-quarter results were strong, with send volume up 41% and revenue up 34%. For the full year, the company expects revenue growth of 25%-26%. With numbers like that, Remitly is clearly gaining market share and capitalizing on the large market for remittances. If regulations don't get in the way, the company should continue to deliver steady growth. Before you buy stock in Remitly Global, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Remitly Global wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $660,821!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $886,880!* Now, it's worth noting Stock Advisor's total average return is 791% — a market-crushing outperformance compared to 174% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Jeremy Bowman has positions in Remitly Global. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Remitly Global Stock Finished Up Almost 6% Today was originally published by The Motley Fool Sign in to access your portfolio
